Menu

Berkeley CRISPR Inventors Get Another Important European Patent

This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.

Mar 12, 2018
Jim Daley

© BRYAN SATALINO

The European Patent Office (EPO) granted a patent for CRISPR-Cas9 applications to Emmanuelle Charpentier, a co-discoverer of CRISPR and the cofounder of ERS Genomics, the University of California, and the University of Vienna. The patent has very broad claims covering the use of the technology and is directed to applications that use a modified version of the Cas9 protein.

This is the second patent issued to the company by the EPO for the gene-editing technology. The first was granted last March for the use of CRISPR across prokaryotic and eukaryotic cells and organisms. The Broad Institute of MIT and Harvard University, on the other hand, has had less luck in Europe—in January, the EPO revoked a foundational patent belonging to the institution because it did not meet the agency’s requirement to establish that its scientists were the first to use CRISPR in eukaryotes.

See “UC Berkeley Receives CRISPR Patent in Europe

The latest patent “addresses yet another set of important applications of the CRISPR technology, which are becoming widely used in new drug discovery efforts and other areas of research,” says Eric Rhodes, CEO of ERS Genomics, in a press release. “This form of CRISPR is broadly enabling as it allows researchers to selectively repress or activate genes of interest to determine their function. It is the newest tool being used to discern the role of genes in disease, ultimately leading to new therapeutic applications.”

The most popular uses of this kind of CRISPR technology are inhibitory CRISPR (CRISPR-i) and activating CRISPR (CRISPR-a), according to the press release. The applications can be used to identify the roles genes play in various cellular processes and disease through a process known as single guide RNA (sgRNA) screening.

“It is gratifying to see CRISPR being deployed so broadly to help identify and understand so many new areas in biology,” Charpentier says in the press release. “The breadth of areas into which CRISPR is now being applied and the impact it is having is truly exciting.”

See “EPO Revokes Broad’s CRISPR Patent

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.